The study examined genetic alterations in more than 3,200 patients with lung cancer, focusing on key genes linked to ...

Mumbai, Maharashtra, India Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 ...

After eight days of severe air pollution, Delhi on Thursday saw slightly improved air quality. At 7 am, the overall Air ...

Metropolis molecular genomics study shows genetic profiling are improving survival rates: Our Bureau, Bengaluru Friday, November 22, 2024, 14:45 Hrs [IST] Metropolis Healthcare co ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations ... Genesis of Lung Adenocarcinoma Feb ...

For instance, adenocarcinoma, which tends to grow ... Genetic testing advancements have drastically transformed nonsmoker lung cancer treatment. Presently, patients can undergo tests to pinpoint ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

Pancreatic cancer is one of the hardest cancers to detect early and treat effectively. By the time it’s discovered, it’s ...

Endometrial cancer is the most prevalent gynaecological cancer in developed countries, especially after menopause.

Protects the use of onvansertib in combination with standard of care in the KRAS mutated mCRC setting through 2043 - SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRDF), a clinical-stage ...

KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer ... muscle invasive ...